Manufacturer
Pharmaniaga Manufacturing Berhad
Contents
Montelukast
Indication
Prophylaxis and chronic treatment of asthma in adults and pediatric patients ≥12 months.
Montelukast is indicated in adults and pediatric patients ≥2 years for the relief of daytime and nighttime symptoms of seasonal allergic rhinitis.
Instruction
May be taken with or without food
Drug interaction
Concomitant use w/ CYP3A4 enzyme inducers. Elevated plasma conc w/ concurrent use of gemfibrozil. May result to severe peripheral edema w/ concurrent use of prednisone. May increased repaglinide plasma conc.
Malaysia
